News
23h
Barchart on MSNEli Lilly vs. Novo Nordisk: Which Stock Is the Winner of the Weight-Loss Drug Boom?The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...
8h
The Print on MSNBig pharma pivoting to more lucrative obesity segment, Indian drugmakers eye insulin marketThe size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...
President Trump’s executive order aims to bring down drug prices while optimizing IP protections, and Congress should pass ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results